Funding for this research was provided by:
Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (20H03941)
Article History
Received: 22 May 2023
Revised: 12 July 2023
Accepted: 16 July 2023
First Online: 24 July 2023
Change Date: 26 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10067-024-06866-y
Declarations
:
: This study was approved by the Institutional Review Board at Kyoto University. We performed this study in accordance with the ethical standards laid out in the 1964 Declaration of Helsinki and its later amendments. The data were obtained by contract from JMDC Inc. and permission was obtained to use them in the study and to publish the results in a scientific paper. Individual consent was not needed because the data were anonymized.
: Koji Kawakami has received research funds from Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Sumitomo Pharma Co., Ltd., Mitsubishi Corporation, and Real World Data Co. Ltd.; consulting fees from LEBER Inc., JMDC Inc., Shin Nippon Biomedical Laboratories Ltd., and Advanced Medical Care Inc.; executive compensation from Cancer Intelligence Care Systems, Inc.; and honoraria from Mitsubishi Corporation, Pharma Business Academy, and Toppan Inc. Other authors have no conflicts of interest to declare.